Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Perspective Therapeutics has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting 5070000.0 for Q1 2024.

• Liabilities from Discontinued Operations for Q1 2024 came in at 5070000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was 5070000.0 (changed N/A YoY), and the FY2023 annual result was 5072000.0, up 1432.33% from the prior year.
• Liabilities from Discontinued Operations came in at 5070000.0 for Q1 2024 at Perspective Therapeutics, roughly flat from 5072000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 5072000.0 in Q4 2023 to a low of 331000.0 in Q4 2022.
• The 3-year median for Liabilities from Discontinued Operations is 5070000.0 (2024), against an average of 3491000.0.
• Peak annual rise in Liabilities from Discontinued Operations reached 1432.33% in 2023, while the deepest fall reached 1432.33% in 2023.
• Perspective Therapeutics' Liabilities from Discontinued Operations stood at 331000.0 in 2022, then jumped by 1432.33% to 5072000.0 in 2023, then dropped by 0.04% to 5070000.0 in 2024.
• The last three Liabilities from Discontinued Operations figures came in at 5070000.0 (Q1 2024), 5072000.0 (Q4 2023), and 331000.0 (Q4 2022), per Business Quant data.